Here, FOLFIRI, Irinotecan+5-Fluorouracil+Leucovorin; IFL, Irinotecan +
5-Fluorouracil; IROX, Irinotecan + Oxaliplatin; FLIRI, Irinotecan +
5-Fluorouracil + Folic acid; XELIRI, Irinotecan + capecitabine +
bevacizumab; Lv5FU2-IRI, Irinotecan + 5-Fluorouracil + Folic acid; U,
Unknown; Invader UGT1A1 Molecular Assay kit, Third Wave Technologies,
Madison, WI, USA; WHO, World Health Organization criteria; NDP,
Nedaplatin
Assessment of studies by NOS indicated that the included studies were of
high quality where the NOS score ranged from ‘7’ to “9’, as shown in
Supplementary Table S1.